← Back to Vaccine Database

BBV152

Inactivated vaccine · VDDBV0114

Target & Classification

SARS-CoV-2SARS-CoV-2
Inactivated vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials4

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04471519 Phase 2COVID-19
NCT04918797 Phase 3COVID-19
NCT05258669 Phase 3COVID-19
NCT04641481 Phase 3COVID-19